64x Bio logo

64x Bio

64x Bio is a biotechnology company developing a platform for improving speed and scalability of mammalian cell line discovery for pharmaceutical and biotechnology companies.

3

Funding Rounds

$59.5m

Money raised

Overview

64x Bio is a biotechnology company developing a platform for improving speed and scalability of mammalian cell line discovery for pharmaceutical and biotechnology companies.

Funding

Funding series

Funding Series Analysis

The company 64x Bio has raised a total of $55m in funding over 3 rounds.

Key Insights:

  • 64x Bio Series A round, January 2022: $55m
  • 64x Bio Seed round, April 2019: $4.5m
64x Bio logo
64x Bio Series A round, January 2022 $55m
64x Bio logo
64x Bio Seed round, April 2019 $4.5m